Avalon GloboCare Corp.
ALBT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.10 | -0.00 | 0.03 | -0.04 |
| FCF Yield | -14.05% | -20.64% | -23.11% | -24.47% |
| EV / EBITDA | -101.54 | -1.14 | -7.90 | -4.53 |
| Quality | ||||
| ROIC | -2.70% | -322.99% | -41.34% | -8.77% |
| Gross Margin | 33.06% | 28.35% | 19.84% | 21.50% |
| Cash Conversion Ratio | 5.35 | 0.09 | 0.73 | 0.40 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.29% | 4.56% | 4.46% | 3.51% |
| Free Cash Flow Growth | -9.69% | 31.16% | -64.89% | 33.33% |
| Safety | ||||
| Net Debt / EBITDA | -42.29 | -0.66 | -3.71 | -2.39 |
| Interest Coverage | -2.43 | -3.68 | -3.23 | -2.33 |
| Efficiency | ||||
| Inventory Turnover | 2.93 | 2.90 | 3.11 | 2.94 |
| Cash Conversion Cycle | 320.34 | 55.51 | 311.97 | 62.59 |